Navigation Links
Nutrastar to Participate in Brean Murray, Carret & Co.'s 2011 Beijing China Growth Conference
Date:6/20/2011

HARBIN, China, June 20, 2011 /PRNewswire-Asia-FirstCall/ -- Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded Traditional Chinese Medicine ("TCM") consumer products, today announced that the Company will be attending the upcoming 2011 BMC Beijing China Growth Conference being held at the JW Marriot Hotel in Beijing, China from June 27th – 28th, 2011. Mr. Robert Tick, Chief Financial Officer, and company management will be presenting on Monday, June 27th from 4:50 p.m. – 5:25 p.m. on Track II. The company will also be conducting one-on-one meetings during the conference.

If you would like to schedule a meeting with Ms. Lianyun Han, Chairman and CEO of Nutrastar and the Company's management team during the conference, please contact Robert Tick via email at roberttick@nutrastarintl.com or your Brean Murray, Carret & Co. representative directly.

About Nutrastar International Inc.Nutrastar is a China based leading producer and supplier of premium branded TCM consumer products including commercially cultivated Chinese Golden Grass ("Cordyceps Militaris") and functional health beverages. Cordyceps Militaris is one of the most highly regarded herbal nutrients in TCM. The Company believes it is the largest manufacturer of bioengineered Chinese Golden Grass in China, ranked by volume, according to China Market Monitoring Center (CMMC), accounting for approximately 19% market share in China. The Company is headquartered in Harbin, capital of Heilongjiang province, with 321 employees, 21 in R&D, and 140 in sales and marketing. The products of Nutrastar are sold throughout China via a direct and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: ir@nutrasta
'/>"/>

SOURCE Nutrastar International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nutrastar to Present at the Cowen and Company 9th Annual Consumer Conference in NYC
2. Nutrastar Announces Record 2010 Performance and Revenue Guidance for 2011
3. Nutrastar Distribution Spreads into Anhui Province
4. Nutrastar Provides First Quarter 2011 Financial Results Release Date and Conference Call Details
5. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
6. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
7. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
8. Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network
9. Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
10. Reproductive Partners Participates in New IVF Progesterone Delivery System Study
11. Atritech to Participate in Late-Breaking Clinical Trial Presentation at American College of Cardiology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Strategic Health Services, Inc. (SHS), a leading provider of ... agreement with QualCare, Inc., a leading provider of health plans ... marketplace.  This agreement will further QualCare,s population health management ... brings to its clients in New Jersey ... QualCare plans cover more than 800,000 member lives, with ...
(Date:12/17/2014)... December 17, 2014 , ... than a hub of information concerning the biopharmaceutical Group,s national ... A further addition to the recently launched institutional website that ... now been enriched by a new chapter in the fascinating ... A richly detailed and panoramic hub on the world of ...
(Date:12/17/2014)... Ga. and RALEIGH, N.C. ... Trial Marketing Communications, LLC (CTMC), and Integrated Clinical ... patient recruitment and retention for clinical trials announce ... Integrated Clinical Trial Marketing Services (i-CTMS). i-CTMS will ... retention services to pharmaceutical, biotechnology and medical device ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... France and SWIFTWATER, Pa., June 16 Sanofi,Pasteur, the ... donate 60 million doses of H5N1 vaccine to the ... of an H5N1 vaccine,global stockpile., "The H5N1 virus ... the world and an outbreak of pandemic influenza would ...
... Results presented at the 90th annual Endocrine Society meeting show,significant ... ... painful intercourse, ANN ARBOR, Mich, June 16 QuatRx ... 3 clinical,trial of Ophena(TM) (ospemifene tablets) to treat postmenopausal women ...
Cached Medicine Technology:Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile 2Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile 3Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile 4Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile 5Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 2Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 3Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 4
(Date:12/19/2014)... 19, 2014 Eufaula, Oklahoma, located just ... Eufaula, the state’s largest lake with more than 600 ... home to a little more than 3,000 residents, hosted ... Saturday, the 6th of December. , Featuring Santa, Christmas ... downtown Eufaula on Main Street. Narconon Arrowhead’s parade ...
(Date:12/19/2014)... The print component of Vision and ... of the Toronto Star, with a circulation of approximately ... digital component is distributed nationally through a vast social ... sites and partner outlets. To explore the digital version ... publication features an exclusive interview with Mark DeMontis ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- Potentially illness-causing E. coli ... at farmers markets, according to a new study. ... vendors from 13 farmers markets in Los Angeles and ... Out of almost 150 samples tested, 24 percent were ... salmonella, according to the researchers. Both types of ...
(Date:12/19/2014)... who have lost all their teeth have faster decreases in ... least some of their teeth, a new study says. ... early warning of increased risk of physical and mental decline ... findings don,t prove that tooth loss causes the physical or ... 60 and older. People with no remaining teeth did about ...
(Date:12/19/2014)... Kan. (PRWEB) December 19, 2014 B. ... exclusively to healthcare providers, has been retained to lead ... Estes Park Medical Center in Estes Park, Colo. The ... E. Smith has recently placed more than 900 healthcare ... (EPMC) is a 25-bed, not-for-profit critical access hospital and ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2Health News:E. Coli Germs Found on Farmers Market Herbs 2Health News:Loss of Teeth Linked to Physical, Mental Decline in Study 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3
... American Society,of Consultant Pharmacists (ASCP) announces that Outcomes ... Medication Therapy,Management (MTM) Provider Partners. This announcement was ... 38th Annual Meeting and Exhibition,taking place in Philadelphia., ... MTM services has increased,dramatically since the coverage of ...
... years that psychological trauma that results in post-traumatic ... a person responds to stress. Now, Cornell researchers ... life-threatening accidents and other such traumas may result ... develop a clinical disorder., "The findings suggest that ...
... JAPAN, November 20, 2007 Bristol-Myers Squibb Company (NYSE: ... the U.S. Food and Drug Administration (FDA) approved the ... add-on, treatment to antidepressant therapy (ADT) in adults with ... medication approved by the FDA as add-on treatment for ...
... 20 Crdentia Corp. (OTC Bulletin,Board: CRDT), a ... Ms. Penny Kirsch to Vice President of Human ... Manager,for Crdentia and will continue to report to ... be responsible for all human resources operations for ...
... Nov. 20 SyntheMed, Inc. (OTC,Bulletin Board: SYMD), a ... and drug delivery products, today,announced that President and CEO ... Markets Fourth Annual Healthcare Conference at the Palace,Hotel in ... 1:30 p.m. EST. Lazard Capital Markets will host ...
... Molecular Imaging Zone, FORT LAUDERDALE, Fla., Nov. ... IMDS) a pioneer in laser,optical breast cancer imaging ... cases imaged with optical computed tomography,technologies at RSNA ... 28. A CT,Laser Mammography (CTLM(R)) system and clinical ...
Cached Medicine News:Health News:Outcomes Pharmaceutical Health Care(r) Becomes an ASCP MTM Provider Partner 2Health News:FDA approves ABILIFY(R) (aripiprazole) as the first medication for add-on treatment of MDD 2Health News:FDA approves ABILIFY(R) (aripiprazole) as the first medication for add-on treatment of MDD 3Health News:FDA approves ABILIFY(R) (aripiprazole) as the first medication for add-on treatment of MDD 4Health News:FDA approves ABILIFY(R) (aripiprazole) as the first medication for add-on treatment of MDD 5Health News:Crdentia Announces Promotion of Penny Kirsch to Vice President of Human Resources 2Health News:Crdentia Announces Promotion of Penny Kirsch to Vice President of Human Resources 3Health News:Imaging Diagnostic Systems to Present Laser Breast Imaging Clinical Results at the 2007 Radiological Society of North America Scientific Assembly 2Health News:Imaging Diagnostic Systems to Present Laser Breast Imaging Clinical Results at the 2007 Radiological Society of North America Scientific Assembly 3
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
The ACMI™ Operative Laparoscopy System is designed for single- and dual-incision CO2 laser procedures and is used with 45cm laparoscopic instruments....
The edge-to-edge clarity of the laparoscopes provides excellent image definition.Even small structures are easily recognized due to the optimal depth of focus. The outstanding optical quality provide...
Stryker bariatric laparoscopes set the standard in picture quality....
Medicine Products: